Spago Nanomedical AB SPAGO
OMXSTO · Sweden · Health Technology
SEK 0.1000+0.00 (+0.81%)
Market closed· · SEK · Data may be delayed
Prices may be delayed and are for informational purposes only - not investment advice.
Market closed· · SEK · Data may be delayed
Prices may be delayed and are for informational purposes only - not investment advice.
Total return, dividends included.
Where the price sits against its 50- and 200-day moving averages.
Makkler Fair Value, financial health score, analyst view, peers and MakklerAI.
LUND, SE / ACCESS Newswire / September 29, 2026 / AB (publ) (STO:SPAGO.F) today announces that the company will participate in five international conferences during autumn 2026, spanning nuclear medicine, radionuclide therapy and life science.
LUND, SE / ACCESS Newswire / September 21, 2026 / (STO:SPAGO.F) - The shareholders of AB (publ), corporate registration number 556574-5048, are hereby summoned to the Extraordinary General Meeting on Thursday 22 October 2026, at 13.
LUND, SE / ACCESS Newswire / August 20, 2026 / Spago Nanomedical (STO:SPAGO.ST)(FRA:7UX.F) APRIL - JUNE IN BRIEF Net sales for the quarter amounted to KSEK 0 (KSEK 81) The loss for the quarter amounted to KSEK -7,331 (KSEK -6,964) Operating expenses ...
Recent third-party headlines about this company, kept separate from Makkler's own editorial coverage and linking out to the publisher. Accuracy is the publisher's responsibility.